Arrowstreet Capital’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-48,453
| Closed | -$612K | – | 2633 |
|
|
2020
Q4 | $612K | Sell |
48,453
-14,400
| -23% | -$182K | ﹤0.01% | 1964 |
|
|
2020
Q3 | $617K | Buy |
62,853
+34,003
| +118% | +$334K | ﹤0.01% | 1961 |
|
|
2020
Q2 | $287K | Buy |
28,850
+6,724
| +30% | +$66.9K | ﹤0.01% | 2116 |
|
|
2020
Q1 | $196K | Buy |
22,126
+8,226
| +59% | +$72.9K | ﹤0.01% | 1735 |
|
|
2019
Q4 | $128K | Buy |
+13,900
| New | +$128K | ﹤0.01% | 1654 |
|
|
2018
Q4 | – | Sell |
-297,864
| Closed | -$4.42M | – | 1550 |
|
|
2018
Q3 | $4.42M | Sell |
297,864
-3,786
| -1% | -$56.2K | 0.01% | 531 |
|
|
2018
Q2 | $5.08M | Buy |
301,650
+9,700
| +3% | +$163K | 0.01% | 543 |
|
|
2018
Q1 | $6.69M | Buy |
291,950
+183,250
| +169% | +$4.2M | 0.02% | 520 |
|
|
2017
Q4 | $2.81M | Buy |
+108,700
| New | +$2.81M | 0.01% | 731 |
|